Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10.
N Engl J Med. 2019.
PMID: 31075187
Clinical Trial.